![]() |
BioTalk UnzippedUnzipping the Stories Behind Medical Progress Author: Gregory Austin
BioTalk Unzipped, hosted by Gregory Austin and Dr. Chad Briscoe, unzips the stories behind medical progress through candid, intelligent, and often entertaining conversations with leaders across biotechnology, pharmaceuticals, medical technology, clinical research, bioanalysis, and drug development. Each episode explores the science, strategy, setbacks, breakthroughs, and human stories shaping the future of medicine. From first-in-human trials and biomarkers to oncology, rare disease, AI, regulatory strategy, and emerging therapeutic technologies, BioTalk Unzipped makes complex life science topics engaging, accessible, and relevant. The show feels like the conversation you would want to overhear after a great scientific conference: thoughtful, unscripted, curious, and grounded in real-world experience. We bring listeners inside the decisions, discoveries, and personal journeys behind the therapies and technologies that may one day reduce suffering and improve lives. Language: en Genres: Health & Fitness, Life Sciences, Medicine, Science Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Why Finding the Right Drug Dose Is So Difficult | Dr. Ewoud-Jan van Hoogdalem
Episode 48
Wednesday, 4 November, 2026
A drug shows promise in a small patient study. How much does that tell you about the dose you should test next?Gregory Austin and Dr. Chad Briscoe explore that question with Dr. Ewoud-Jan van Hoogdalem, a board-certified clinical pharmacologist and former Vice President of Clinical Pharmacology at ICON. He explains how first-in-human studies inform dose selection, why an early signal in patients can leave important questions unanswered, and how a dose that makes it through development can still prove difficult for patients to tolerate in everyday use.Drawing on his experience in small biotech and large pharma, Ewoud-Jan also discusses when combining study objectives makes sense and how teams decide which evidence they can afford to go without.Connect with Ewoud-Jan on LinkedIn:https://www.linkedin.com/in/ewoud-jan-van-hoogdalem-6836012/Ewoud-Jan’s chosen charity is Doctors Without Borders (Médecins Sans Frontières).https://www.doctorswithoutborders.org/THANK YOU TO OUR SPONSORSTruTechnologies: The industry’s first Live Clinical Trial Execution platform, helping research teams prevent errors while giving sponsors instant visibility into trial activity.https://trutechnologies.ai/Leucentra: Inspired by science, empowered by IT.https://leucentra.com/








